The sirtuin pathway in ageing and Alzheimer disease: mechanistic and therapeutic considerations
- 31 March 2011
- journal article
- review article
- Published by Elsevier BV in The Lancet Neurology
- Vol. 10 (3), 275-279
- https://doi.org/10.1016/s1474-4422(11)70013-8
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Alzheimer DiseaseDisease-a-Month, 2010
- Spatial correlation between brain aerobic glycolysis and amyloid-β (Aβ) depositionProceedings of the National Academy of Sciences of the United States of America, 2010
- Regional aerobic glycolysis in the human brainProceedings of the National Academy of Sciences of the United States of America, 2010
- RETRACTED: SIRT1 Suppresses β-Amyloid Production by Activating the α-Secretase Gene ADAM10Cell, 2010
- A novel pathway regulates memory and plasticity via SIRT1 and miR-134Nature, 2010
- Sirt1 improves healthy ageing and protects from metabolic syndrome-associated cancerNature Communications, 2010
- The NAD+-Dependent Deacetylase SIRT1 Modulates CLOCK-Mediated Chromatin Remodeling and Circadian ControlCell, 2008
- Mitochondria—A Nexus for Aging, Calorie Restriction, and Sirtuins?Cell, 2008
- SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosisThe EMBO Journal, 2007
- Metabolic regulation of SIRT1 transcription via a HIC1:CtBP corepressor complexProceedings of the National Academy of Sciences of the United States of America, 2007